PEMPHIGUS VULGARIS TREATMENT MARKET ANALYSIS

Pemphigus Vulgaris Treatment Market, by Drug (Azathioprine, Rituximab, Cyclophosphamide, Cyclosporine, Pipeline Drugs (PRN1008) and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2530
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Pemphigus Vulgaris Treatment Market Key Players

Some of the key players operating in the global pemphigus vulgaris treatment market include, Principia Biopharma, Argenx SE, Alexion Inc., Genentech, Inc., Novartis International AG, GlaxoSmithKline plc. Vifor Pharma Management Ltd., and F. Hoffmann-La Roche AG